Defibrillators made by St Jude Medical are prone to battery failure, FDA warns
BMJ 2016; 355 doi: https://doi.org/10.1136/bmj.i5571 (Published 14 October 2016) Cite this as: BMJ 2016;355:i5571- Michael McCarthy
- Seattle
Two defibrillators manufactured by St Jude Medical are prone to failure because of faulty batteries, the US Food and Drug Administration (FDA) warned in a safety communication issued on 11 October.1
The warning applies to implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy defibrillators (CRT-D) manufactured before May 2015, which are used to provide pacing for patients with bradycardia, defibrillation for those with dangerous tachycardias, and synchronization to improve cardiac function in patients with heart failure.
The devices should issue an alert, known as an elective replacement indicator (ERI) alert, when their batteries are …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.